Xenetic Biosciences is trading 7.78% up in after-hours trading at $4.99, amid broader biotech momentum and a strong risk-on session.
- It gained 8.94% during the September 3, 2026 regular session.
- No new company-specific announcement or SEC filing was identified for September 3; the latest reported release was the August 7 second-quarter update.
- Major U.S. indexes rose more than 0.9%.